AbbVie's Deal with Apogee; Regenxbio Acts on Gene Therapy Drug | Stock Movers
Corroborated by 2 sources from 2 publishers
globalhealth1d ago
TL;DR
Reports differ across sources; according to finance.yahoo.com, on this episode of Stock Movers with Nathan Hager:- Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics.